s,n,n'-tripropylthiocarbamate has been researched along with Peripheral Nerve Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bagdas, D; Bigbee, JW; Cantwell, L; Chen, ZJ; Damaj, MI; Del Fabbro, E; Gewirtz, DA; Jackson, A; Kulkarni, A; Kyte, SL; Meade, JA; Papke, RL; Rahman, F; Thakur, GA; Toma, W | 1 |
| Bhargava, A; Jasmin, L; Ohara, PT; Vit, JP | 1 |
2 other study(ies) available for s,n,n'-tripropylthiocarbamate and Peripheral Nerve Diseases
| Article | Year |
|---|---|
The α7 nicotinic receptor silent agonist R-47 prevents and reverses paclitaxel-induced peripheral neuropathy in mice without tolerance or altering nicotine reward and withdrawal.
Topics: A549 Cells; alpha7 Nicotinic Acetylcholine Receptor; Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Drug Tolerance; Humans; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Nicotine; Nicotinic Agonists; Paclitaxel; Peripheral Nervous System Diseases; Piperazines; Reward | 2019 |
Can satellite glial cells be therapeutic targets for pain control?
Topics: Animals; Bromodeoxyuridine; Cell- and Tissue-Based Therapy; Connexin 43; Disease Models, Animal; Ectodysplasins; Facial Pain; Gap Junctions; Glutamate Synthase; Male; Membrane Cofactor Protein; Models, Biological; Neuroglia; Pain; Pain Management; Pain Measurement; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley; Reward; RNA, Double-Stranded; Small-Conductance Calcium-Activated Potassium Channels; Trigeminal Ganglion | 2010 |